Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Clinical trial NCT01336465 · COMPLETED
Trial details
- NCT number
- NCT01336465
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2012-09-01
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.